A fast-acting form of medicine that works like a powerful anti-oxidant is helping thousands of patients in the United States and elsewhere to avoid getting sick from car jackings.
The new medication, called “FastMed Rapid,” is designed to rapidly revive the dead or dying from car wrecks.
“FastMed Quick” is also being tested on more than 1,000 people a week for its ability to treat a variety of conditions, including cancer, diabetes, heart disease, obesity, and more, said Dr. Michael Schoenfeld, director of the FastMed Institute, a nonprofit research group based in Austin, Texas.
FastMed Quick is not FDA-approved for treatment of cancer, but it works similarly to the newer “bio-proprietary” drugs, such as Celebrex.
In most cases, fastMed Quick will kill the cancerous cells and kill the cells that are still causing inflammation and damage.
But in rare cases, the drug could be harmful, like for some people with certain forms of colon cancer.
Fast Med Quick has shown success in other studies.
In one, it was shown to treat kidney cancer.
Schoenfeld said that FastMed Rapid, which was approved by the Food and Drug Administration in June, has been used to treat cancerous tumors in some people in at least three different cancer types.
While the drug is approved for use in people with a few conditions that cause inflammation and cancerous growths, such cancerous conditions include pancreatic cancer, prostate cancer, and a few other types of cancer.
There have been about 5,000 FastMed prescriptions for the drug, he said.
About 1,500 patients have been treated with the drug so far, he added.
FastMED Rapid has been tested on about 400 people, but its effectiveness in those trials was limited because of the limited number of people receiving it, Schoenfield said.
FastMD Rapid is only available for use at hospitals and clinics.
People who have a family member or close friend who is cancer-prone are eligible for FastMed, but not everyone is eligible, Schenfeld said.
People must have a diagnosis of one of the following types of colorectal cancer: acute or chronic, non-small cell, or coloretypal.
FastMeds Rapid is currently in phase II trials with a limited number that will expand FastMed to more people, he explained.
For more information on FastMed FastMed is a powerful drug designed to fast-track the treatment of cancers that cause abnormal growths.
The drug is a “biosynthetic” form of the drug Celebrexes that works by producing a drug called Celebrexa.
It works by rapidly replacing damaged or dead cells in a patient’s cells, and by targeting the wrong kind of cells in the tumor.
FastMed, which is manufactured by Pfizer, was developed by Dr. Robert Siegel, a biochemist and professor of medicine at the University of Texas Southwestern Medical Center.
He was the founder of Pfizer’s research group, which produced Celebrexs.
Schoenfield and his colleagues are studying FastMed in about 600 people, with the goal of testing its efficacy in 10,000 patients a week.
It’s hoped that the drug will be available by the end of the year.
It was originally tested on a small number of cancer patients.
Fastmed Rapid has already been tested in the treatment in about 300 people, Schowfeld said, and he expects to have about 1,200 patients receiving FastMed soon.
FastMed has a waiting list of more than 4,000.
Fast Medic Quick will be made available to people who have already taken the drug and can prove they need it, according to Schoenfort.
Fastmed Rapid, a synthetic version of Celebrexc, is being developed by Pfizers Therapeutics, Inc., of Fort Worth, Texas, according.
Pfizer did not immediately respond to a request for comment.
Schowfeld described FastMed as a powerful treatment for many different cancers, including breast, prostate, colorecy, lung, and pancreatic.
FastMe Rapid is designed for people who suffer from colorectoral, pancreatic, colon, and ovarian cancers.
FastME Rapid is being tested in a larger number of patients, including more than 600, he noted.
There have been more than 40 studies of FastMed and FastMed Speed, with more than 2,300 people being treated, Schoofer said.
Schoofer, who has worked with Pfizer since the 1980s, said FastMed has been proven to treat all kinds of cancers.
“The best part is the combination of the two drugs,” he said, referring to Celebrexus and FastMED.
FastMedic is FDA- approved for the treatment, but there are side effects, including a higher risk of side effects like side effects from chemotherapy. Most